Bank of Montreal
NBSE

Bank of Montreal’s NeuBase Therapeutics, Inc. Common Stock NBSE Stock Holding History

Bank of Montreal’s Portfolio NBSE Stock Details NBSE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-11
Closed -$11K – 4149
2015
Q1 		$11K Buy
+11
New +$36.3K ﹤0.01% 3476

Other funds holding NBSE

GC
Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
JAMONY
Jacob Asset Management of New York Hermosa Beach, California $70.9M AUM 14.28% 1-Year Est. Return
PCM
Prelude Capital Management New York $1.31B AUM 62.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of Montreal's NBSE Position: Q2 2021 in Review

Bank of Montreal sold out of NeuBase Therapeutics, Inc. Common Stock (NBSE) in Q2 2021, closing a stake of 23 shares — an estimated $3K sold.

Bank of Montreal first reported a position in NBSE in Q1 2015 and held it in 11 quarters. The position peaked at $31K in Q4 2015. 57 funds tracked by Wall St. Rank hold NBSE as of Q2 2021.

  • Bank of Montreal reported no remaining NeuBase Therapeutics, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Bank of Montreal sold 23 NeuBase Therapeutics, Inc. Common Stock shares in Q2 2021, an estimated $3K.
  • Bank of Montreal first reported a position in NeuBase Therapeutics, Inc. Common Stock in Q1 2015 and held it in 11 quarters.
  • Bank of Montreal's NeuBase Therapeutics, Inc. Common Stock position peaked at $31K in Q4 2015.
  • 57 funds tracked by Wall St. Rank held NeuBase Therapeutics, Inc. Common Stock as of Q2 2021.

Based on Bank of Montreal's 13F filing for Q2 2021, filed 12 Aug 2021.